In Indonesia, the vaccine developed by the US biotech company NovaVax has been certified for emergency use. The Novavax vaccine was approved for the first time in Indonesia.
After gaining the permission on Monday, NovaVax's CEO told Reuters that they believed the vaccine will be licensed in a few weeks in several countries, including India and the Philippines.